Junzo Hamanishi

40PUBLICATIONS
158CO-AUTHORS
Tumour immunologyPredictive and prognostic markersObstetrics and gynaecologyCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples sport and physical activity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 10, 2026
AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 Study.

|Mar 12, 2026
A novel CDK12 inhibitor induces homologous recombination deficiency to enhance PARP inhibitor efficacy in uterine serous carcinoma.

Shunsuke Kawahara, Mana Taki, Junzo Hamanishi

|Feb 16, 2026
Title: AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 study.

Kohei Hamada, Junzo Hamanishi, Akihiko Ueda

|Jan 27, 2026
Oligoclonal B cell expansion and passenger fusion genes predict response to Nivolumab in recurrent ovarian cancer: phase II Kyoto trial.

Ryusuke Murakami, Junzo Hamanishi, J B Brown

|Dec 15, 2025
High-grade gliomas derived from an ovarian mature teratoma: clonal dynamics and genetic insights.

Kota Yamauchi, Junzo Hamanishi, Koichi Watanabe

|Jul 01, 2025
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial.

Shin Nishio, Tadaaki Nishikawa, Masahiko Mori

Pageof 7

Frequent Collaborators

14 joint publications

Ken Yamaguchi

10 joint publications

Noriomi Matsumura

10 joint publications

Masaki Mandai

9 joint publications

Koji Yamanoi